Table 2 Baseline demographic and clinical characteristics of H1- antihistamine-refractory CU patients
Region EU | Region C/SA | Significance Test Statistic | |
|---|---|---|---|
Age (years) | 46.0 ± 15.5 | 42.0 ± 13.8 | F = 29.57; P < 0.001 |
Female: n (%) | 2642 (70.8) | 390 (72.3) | Chi2 = 15.350; P < 0.001 |
BMI (kg/m2)a | 26.8 ± 5.4 | 26.3 ± 4.2 | F = 1.58; P = 0.209 |
Underweight: n (%) | 43 (1.3) | 4 (1.7) | Chi2 = 5.436; P = 0.143 |
Healthy weight: n (%) | 1361 (40.9) | 99 (40.7) | |
Overweight: n (%) | 1157 (34.8) | 98 (40.3) | |
Obese: n (%) | 764 (23.0) | 42 (17.3) | |
Diagnosis: n (%) | |||
CSU only | 2725 (73.1) | 303 (65.3) | Chi2 = 17.285; P = 0.001 |
CIndU only | 215 (5.8) | 31 (6.7) | |
Both CSU and CIndU | 756 (20.3) | 129 (27.8) | |
CSU with angioedema | 1721 (46.1) | 250 (50.8) | Chi2 = 6.839; P = 0.03 |
Time since diagnosis (years) | 4.8 ± 7.2 | 3.0 ± 4.9 | F = 23.33; P < 0.001 |
UCT scoreb | 7.8 ± 4.3 | 7.2 (4.1) | F = 5.86; P = 0.016 |
UCT scores < 12: n (%)b | 2277 (77.5) | 391 (82.8) | Chi2 = 6.867; P = 0.009 |